patient
lad
ii
show
absenc
hantigen
surfac
erythrocyt
bombay
phenotyp
antih
antibodi
present
serum
sialyllewi
x
hantigen
fucosyl
carbohydr
fucos
bound
manner
nacetylglucosamin
galactos
respect
furthermor
lewi
blood
group
antigen
miss
patient
lad
ii
absenc
fucos
differ
glycosid
linkag
multipl
glycan
strongli
argu
specif
fucosyl
transferas
defici
lad
ii
favor
gener
defect
fucos
metabol
fucos
util
fucosyltransferas
golgi
complex
guanosin
diphosphatefucos
synthes
cytoplasm
import
organel
gdpfucos
biosynthesi
occur
convers
gdpmannos
origin
mannos
uptak
cell
fructos
remain
made
fucos
salvag
pathway
degrad
glycoconjug
exogen
fucos
previou
evid
suggest
lad
ii
caus
deleukocyt
adhes
defici
ii
first
describ
nonrel
children
consanguin
parent
etzioni
et
al
frydman
et
al
live
patient
identifi
sinc
recent
studi
describ
biochem
investig
cell
deriv
abortu
famili
describ
children
lad
ii
common
spectrum
clinic
find
physic
examin
reveal
flat
face
broad
depress
nasal
bridg
antevert
nostril
long
eyelash
short
arm
leg
l
leukocyt
adhes
defici
ii
syndrom
gener
defect
fucos
metabol
thorsten
marquardt
md
crowd
toe
report
one
patient
children
sever
failur
thrive
consider
psychomotor
retard
magnet
reson
imag
scan
brain
show
frontal
cerebr
atrophi
laboratori
investig
reveal
highli
elev
number
peripher
neutrophil
fluorescenceactiv
cell
sort
analysi
neutrophil
antigen
reveal
characterist
absenc
sialyllewi
x
carbohydr
structur
requir
roll
neutrophil
endotheli
cell
extravas
blood
group
type
leukocyt
adhes
defici
ii
describ
patient
herein
report
extens
investig
anoth
patient
physic
stigmata
detect
prenat
ultrasonograph
investig
sialyllewi
x
sle
x
absent
surfac
polymorphonuclear
neutrophil
cell
bind
eand
pselectin
sever
impair
caus
immunodefici
elev
peripher
neutrophil
count
occur
within
sever
day
birth
sever
hypofucosyl
glycoconjug
bear
fucos
differ
glycosid
link
present
cell
type
investig
demonstr
leukocyt
adhes
defici
ii
disord
leukocyt
gener
inherit
metabol
diseas
affect
metabol
fucos
j
pediatr
fect
convers
gdpmannos
gdpfucos
herein
report
clinic
biochem
characterist
third
child
lad
ii
flow
cytometr
analysi
cell
surfac
marker
express
peripher
blood
cell
incub
minut
room
temperatur
combin
follow
antibodi
antihladrpercp
becton
dickinson
heidelberg
germani
isothiocyan
coulterimmunotech
hamburg
germani
addit
cell
stain
unspecif
isotyp
control
antibodi
subsequ
red
cell
lyse
fac
lyse
solut
becton
dickinson
sampl
wash
twice
phosphatebuff
salin
buffer
data
acquisit
analysi
perform
facscalibur
use
cellquest
softwar
becton
dickinson
detail
analysi
peripher
blood
leukocyt
separ
erythrocyt
centrifug
discontinu
ficol
gradient
densiti
sigma
use
amount
cell
per
analysi
granulocyt
popul
defin
forward
sideward
scatter
incub
analyz
antibodi
fc
receptor
block
antibodi
antibodi
antibodi
per
cell
obtain
medarex
inc
annandal
nj
cell
incub
separ
aliquot
purifi
biotinyl
selectinigg
vascular
endothelialcadherinigg
fusion
protein
hank
buffer
salt
solut
contain
fetal
calf
serum
azid
bind
specif
control
incub
second
sampl
phosphatebuff
salin
solut
contain
mmoll
ethylenediaminetetraacet
acid
azid
incub
monoclon
antibodi
antisl
x
mous
igm
obtain
atcc
done
hybridoma
supernat
cell
wash
buffer
first
reagent
detect
either
rphycoerythrinconjug
streptavidin
fitcconjug
rabbit
antimous
igm
antibodi
obtain
jackson
immunoresearch
laboratori
dianova
hamburg
germani
analysi
hantigen
erythrocyt
separ
peripher
blood
leukocyt
ficol
gradient
erythrocyt
incub
antih
antigen
monoclon
antibodi
obtain
mast
diagnostica
reinfeld
germani
detect
fitcconjug
rabbit
antimous
igm
antibodi
describ
immunoglobulin
fusion
protein
biotinyl
incub
purifi
fusion
protein
mgml
mgml
sulfonhydroxysuccinimidebiotin
pierc
rockford
ill
minut
reaction
stop
addit
tri
merck
darmstadt
germani
final
concentr
moll
dialysi
phosphatebuff
salin
solut
control
patient
fibroblast
plate
grown
cell
cultur
plate
describ
previous
label
hour
mannos
label
serumfre
minim
essenti
medium
contain
mmoll
glucos
bovin
serum
albumin
cell
scrape
immedi
mmoll
tri
mmoll
edta
ph
boil
minut
water
bath
free
h
mannos
label
metabolit
eg
mannos
phosphat
gdpmannos
dolicholphosph
mannos
dolichollink
oligosaccharid
remov
sequenti
extract
mmoll
tri
mmoll
edta
ph
chloroform
methanol
chloroformmethanolwat
remain
pellet
redissolv
mmoll
tri
ph
sodium
dodecyl
sulfat
heat
minut
treat
pronas
boehring
mannheim
hour
digest
termin
heat
inactiv
minut
glycopeptid
desalt
sephadex
column
subject
len
culinari
lectin
affin
chromatographi
describ
previous
bound
glycopep
tide
elut
mmoll
methyl
sigma
analyz
liquid
scintil
count
leukocyt
prepar
use
neutrophil
isol
medium
nim
paesel
lorei
hanau
germani
centrifug
cell
fix
paraformaldehyd
mmoll
acid
prepar
thin
frozen
section
immunogold
label
previous
describ
thin
frozen
section
incub
fc
block
unspecif
bind
site
follow
incub
fitcconjug
ulex
europaeu
lectin
camon
wiesbaden
germani
concentr
lectin
bind
site
detect
rabbit
antifluorescein
igg
molecular
probe
leiden
netherland
dilut
fc
goat
antirabbit
igg
conjug
nm
gold
particl
dianova
dilut
fc
control
label
procedur
perform
without
addit
ulex
europaeu
agglutinin
show
bind
site
boy
first
child
nonconsanguin
parent
howev
parent
may
distantli
relat
ancestor
live
small
villag
turkey
fig
first
intrauterin
ultrasonograph
investig
done
week
gestat
reveal
sever
retard
growth
fetal
limb
bone
second
evalu
perform
birth
show
even
pronounc
deviat
regular
growth
curv
data
shown
refer
valu
report
merz
et
al
child
deliv
cesarean
section
week
pregnanc
fetal
heart
rate
monitor
reveal
patholog
pattern
birth
weight
g
percentil
length
birth
cm
percentil
head
circumfer
cm
percentil
broad
depress
nasal
bridg
seen
short
arm
leg
present
broad
palm
simian
creas
note
dorsal
posit
second
toe
overlap
first
third
toe
fig
chromosom
abnorm
found
karyotyp
xy
meconium
ileu
necessit
surgeri
first
day
life
sever
sever
septic
event
occur
first
month
life
requir
intraven
antibiot
therapi
antibiot
prophylaxi
differ
drug
necessari
life
attempt
discontinu
antibiot
prophylaxi
result
high
fever
impair
clinic
condit
within
sever
day
even
antibiot
prophylaxi
mani
episod
high
fever
led
hospit
patient
cultur
blood
cerebrospin
fluid
sampl
obtain
episod
alway
steril
infecti
agent
repeatedli
found
coronaviru
stool
sampl
postnat
growth
sever
impair
bodi
length
weight
gain
head
circumfer
remain
percentil
data
shown
sever
ultrasonograph
investig
brain
first
month
life
reveal
abnorm
month
magnet
reson
imag
perform
reveal
slight
enlarg
frontal
subarachnoid
space
fig
bulg
larg
anterior
fontanel
observ
sever
occas
lumbar
punctur
reveal
increas
intracrani
pressur
cerebrospin
fluid
cell
count
alway
within
normal
rang
today
month
age
boy
sever
neurodevelopment
delay
promin
muscular
hypotonia
unabl
sit
without
support
directli
deliveri
peripher
leukocyt
count
neutrophil
peripher
leukocyt
count
normal
first
day
life
fig
inset
thereaft
total
leukocyt
count
constantli
elev
absenc
infect
total
peripher
leukocyt
count
around
febril
episod
reach
fig
left
panel
differenti
count
demonstr
addit
neutrophil
total
lymphocyt
also
elev
fig
middl
panel
fac
analysi
express
hladr
reveal
normal
distribut
lymphocyt
subpopul
shown
peripher
leukocyt
count
parent
normal
increas
neutrophil
granulocyt
often
parallel
increas
serum
concentr
creactiv
protein
indic
inflammatori
activ
bodi
fig
right
panel
persist
elev
peripher
leukocyt
count
fac
scan
analysi
leukocyt
antigen
perform
boy
month
age
fac
analysi
reveal
absenc
fig
indic
absenc
le
x
leukocyt
surfac
granulocyt
popul
test
monoclon
antibodi
recogn
sle
x
virtual
sle
x
found
cell
surfac
fig
b
sialyllewi
x
carbohydr
structur
neutrophil
necessari
interact
selectin
express
endotheli
cell
bind
eand
pselectin
essenti
roll
neutrophil
endotheli
cell
layer
extravas
biotinyl
solubl
selectin
fusion
protein
use
test
selectin
bind
patient
granulocyt
sever
decreas
capac
patient
granulocyt
bind
eand
pselectin
found
fig
c
indic
absenc
sle
x
like
carbohydr
structur
could
serv
selectin
ligand
result
indic
absenc
lad
ii
cell
directli
birth
blood
group
patient
determin
rhdposit
ccdee
kell
anti
genneg
presenc
blood
group
conclud
patient
erythrocyt
react
antia
antib
sera
sera
newborn
normal
contain
isoagglutinin
erythrocyt
routin
check
presenc
hantigen
rariti
bombay
blood
group
western
europ
bombay
phenotyp
patient
miss
time
month
age
h
bombay
blood
group
phenotyp
detect
convent
analysi
difficult
blood
transfus
rhdneg
erythrocyt
concentr
done
day
life
treat
anemia
caus
prematur
sever
sever
system
infect
reason
monoclon
antibodi
hantigen
use
search
hantigen
express
surfac
patient
erythrocyt
distinguish
transfus
erythrocyt
popul
patient
fac
profil
patient
erythrocyt
ident
genuin
bombay
blood
antih
antibodi
use
small
popul
transfus
erythrocyt
hantigen
express
detect
month
last
transfus
fig
e
indic
occur
either
month
age
antih
antibodi
present
howev
month
age
lowtit
igm
antibodi
detect
caus
incomplet
lysi
rhdneg
erythrocyt
lysi
could
detect
serum
undilut
antibodi
like
repres
antih
antibodi
describ
patient
erythrocyt
patient
lad
ii
fucosyl
lewi
antigen
le
le
b
surfac
howev
absenc
le
le
b
inform
patient
could
also
inherit
parent
mother
blood
group
ccdee
le
ab
father
blood
group
ccdee
le
ab
parent
hantigen
father
child
nonsecretor
blood
group
antigen
wherea
mother
show
secretor
statu
mean
presenc
abo
antigen
saliva
absenc
sle
x
hantigen
demonstr
neither
link
fucos
present
patient
fucosespecif
lectin
use
studi
level
fucosyl
particular
presenc
glycoconjug
differ
cell
type
uea
fucosespecif
lectin
recogn
fucos
differ
glycosid
bond
concentr
creactiv
protein
serum
right
panel
normal
valu
leukocyt
neutrophil
lymphocyt
creactiv
protein
mgdl
cyte
thrombocyt
fibroblast
incub
lectin
lectin
bind
visual
use
immunogold
label
leukocyt
thrombocyt
mark
decreas
lectin
bind
found
lad
ii
cell
granul
control
leukocyt
strongli
label
uea
wherea
granul
patient
leukocyt
weakli
label
neutrophil
prepar
contain
platelet
granul
plasma
membran
reveal
mani
uea
bind
site
contrast
platelet
patient
free
uea
label
fig
uea
bind
modestli
reduc
patient
fibroblast
result
confirm
hypofucosyl
differ
cell
type
lad
ii
control
unspecif
bind
unblock
fc
receptor
cell
surfac
vecadherinigg
fusion
protein
use
blue
vecadherin
specif
bind
neutrophil
surfac
antigen
bind
selectin
ligand
ca
depend
selectin
bind
investig
presenc
red
absenc
green
calcium
control
cell
selectin
bind
complet
suppress
absenc
calcium
occur
lad
ii
cell
littl
selectin
bind
observ
chang
absenc
dival
cation
pselectin
bind
contrast
control
cell
small
decreas
pselectin
bind
observ
absenc
calcium
e
hantigen
express
erythrocyt
b
c
e
drate
structur
show
highaffin
bind
presenc
core
fucos
residu
fibroblast
label
h
mannos
glycopeptid
prepar
lectin
coupl
gel
matrix
glycopeptid
pass
column
bound
glycopeptid
elut
methyl
contrast
control
littl
materi
specif
bound
column
lad
ii
sampl
fig
defect
mannos
metabol
lead
carbohydratedefici
glycoprotein
syndrom
rule
patient
lad
ii
marquardt
unpublish
result
therefor
experi
demonstr
core
fucosyl
defect
lad
ii
fibroblast
lad
ii
cell
express
diseas
phenotyp
articl
report
third
patient
lad
ii
first
born
nonconsanguin
parent
strongli
resembl
patient
morpholog
stigmata
lack
sle
x
hantigen
leukocyt
erythrocyt
respect
show
inabl
neutrophil
bind
endotheli
selectin
peripher
leukocyt
count
constantli
elev
third
day
life
eventu
led
diagnosi
disord
come
steril
intrauterin
environ
surgeri
necessit
meconium
ileu
first
day
life
might
trigger
releas
neutrophil
granulocyt
bone
marrow
leukocyt
unabl
extravas
blood
stream
sle
x
defici
impair
extravas
led
mani
infecti
complic
predomin
clinic
problem
first
year
life
patient
fucos
miss
broad
spectrum
symptomsrang
len
culinari
bind
glycopeptid
fibroblast
mannos
label
sampl
applic
column
wash
remov
label
materi
specif
bound
column
maxim
count
present
first
fraction
void
volum
cpm
second
fraction
control
cpm
second
fraction
lad
ii
cell
peak
cut
diagram
addit
methyl
mannopyranosid
label
glycopeptid
elut
control
wherea
count
elut
lad
ii
cell
circl
control
squar
lad
ii
cell
morpholog
abnorm
retard
growth
psychomotor
retard
immunodeficiencyind
import
fucosyl
requir
gdpfucos
sugar
nucleotid
gener
cytoplasm
predominantli
gdpmannos
import
golgi
complex
transfer
glycoconjug
differ
fucosyltransferas
gener
hypofucosyl
found
lad
ii
suggest
decreas
avail
gdpfucos
differ
fucosyl
process
exact
molecular
defect
lad
ii
identifi
yet
contrast
report
convers
gdpmannos
gdpfucos
affect
patient
lad
ii
fucos
supplement
correct
defect
fibroblast
patient
current
elucid
vivo
patient
natur
molecular
defect
benefit
fucos
therapi
current
investig
